Follicular Lymphoma

News

FDA approves drug to treat relapsed FL

The US Food and Drug Administration (FDA) has granted accelerated approval to copanlisib (Aliqopa), an intravenous PI3K inhibitor developed by...

News

Drug receives priority review for FL

The US Food and Drug Administration (FDA) has granted priority review to a supplemental biologics license application (sBLA) for obinutuzumab (...

Pages